Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients
Clinical trial NCT05443646 · UNKNOWN
Trial details
- NCT number
- NCT05443646
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-23
- Primary completion
- 2024-06-30
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.